PLIAFX PRIME
|
|
United States Patent and Trademark Office
|
5
|
2020-01-21
|
|
|
details
|
HUGENTRA
|
|
United States Patent and Trademark Office
|
1, 5
|
2019-11-12
|
|
|
details
|
SYMALIGN
|
|
United States Patent and Trademark Office
|
5
|
2019-07-16
|
|
|
details
|
MATRION
|
|
World Intellectual Property Organisation
|
5
|
2018-07-26
|
2028-07-26
|
|
details
|
READIGRAFT BLX
|
|
United States Patent and Trademark Office
|
5
|
2018-07-10
|
|
|
details
|
PLIAFX
|
|
United States Patent and Trademark Office
|
5
|
2018-04-24
|
|
|
details
|
VIVIGEN FORMABLE
|
|
United States Patent and Trademark Office
|
5
|
2017-10-10
|
|
|
details
|
PliaFX
|
|
World Intellectual Property Organisation
|
5
|
2017-08-11
|
2027-08-11
|
|
details
|
THE RIGHT CELLS. THE RIGHT TIME.
|
|
World Intellectual Property Organisation
|
5
|
2017-06-13
|
2027-06-13
|
|
details
|
THE RIGHT CELLS. THE RIGHT TIME. THE RIGHT FORMS.
|
|
World Intellectual Property Organisation
|
5
|
2017-06-13
|
2027-06-13
|
|
details
|
THE RIGHT CELLS. THE RIGHT TIME. THE RIGHT FORMS.
|
|
United States Patent and Trademark Office
|
5
|
2017-06-13
|
|
|
details
|
THE RIGHT CELLS. THE RIGHT TIME.
|
|
United States Patent and Trademark Office
|
5
|
2017-06-13
|
|
|
details
|
CARDIOGRAFT MC
|
|
United States Patent and Trademark Office
|
5
|
2017-04-11
|
|
|
details
|
LIFENET HEALTH SAVING LIVES. RESTORING HEALTH. GIVING HOPE.
|
|
United States Patent and Trademark Office
|
5, 37, 44
|
2017-03-14
|
|
|
details
|
VIVIGEN FORMABLE
|
|
World Intellectual Property Organisation
|
5
|
2016-09-30
|
2026-09-30
|
|
details
|
HUGENTRA
|
|
World Intellectual Property Organisation
|
1, 5, 42
|
2016-06-30
|
2026-06-30
|
|
details
|
HUGENESIS
|
|
World Intellectual Property Organisation
|
1, 5, 42
|
2016-06-30
|
2026-06-30
|
|
details
|
BIOWASHER
|
|
United States Patent and Trademark Office
|
5
|
2015-08-11
|
|
|
details
|
VIVIGEN
|
|
United States Patent and Trademark Office
|
5
|
2014-12-23
|
|
|
details
|
FLEXIGRAFT
|
|
United States Patent and Trademark Office
|
5
|
2013-11-12
|
|
|
details
|